BlackRock Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BlackRock Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.73M	Buy	106,963 +7,045	+7%	+$128K	﹤0.01%	1870
2016 Q3	$1.81M	Sell	99,918 -3,973	-4%	-$77.6K	﹤0.01%	1689
2016 Q2	$1.71M	Buy	103,891 +2,972	+3%	+$48.1K	﹤0.01%	1646
2016 Q1	$1.67M	Buy	100,919 +17,505	+21%	+$306K	﹤0.01%	1643
2015 Q4	$1.81M	Buy	83,414 +1,142	+1%	+$22.2K	﹤0.01%	1545
2015 Q3	$1.63M	Sell	82,272 -162,848	-66%	-$5.15M	﹤0.01%	1612
2015 Q2	$8.52M	Buy	+245,120	New	+$7.48M	﹤0.01%	1007
2014 Q3	–	Sell	-37,522	Closed	-$593K	–	2908
2014 Q2	$593K	Buy	+37,522	New	+$536K	﹤0.01%	2130

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return